Blogs

Why is it that so many people, even some astute critics of the traditional mental health system who are happy to challenge the pathologizing of emotional distress generally, cling uncritically to the term and concept of “eating disorders”?

MIA's Justin Karter interviews two leaders of the Task Force on Diagnostic Alternatives, a group of mental health professionals who have issued an open letter demanding a new look at psychiatric diagnosis.

An interview with Professor John Read who joins us to discuss the UK licensing of esketamine nasal spray (Spravato) for so-called ‘Treatment Resistant Depression’. John led a group of 12 academics and professionals who wrote to the UK regulator expressing concerns.

It took me a long time to realise that I was being gaslighted. In fact, I had no word to describe the experience until years after I had finally escaped, when I came across the term by chance. What is worse, whenever I talk about my past relationship now with friends in my new life, I am horrified to discover how common manipulative relationships are.

The UK’s Medicines & Healthcare Products Regulatory Agency is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression.